ANDA 206881, held by Strides Pharma. Potassium Chloride.
As of Nov 15, 2026, ANDA 206881 (Potassium Chloride), held by Strides Pharma, was first approved by FDA on Jan 22, 2019, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jan 22, 2019 | Original application | Approved | None posted |
| Potassium Chloride8MEQ · tablet, extended release;oral | Potassium Chloride | Discontinued |
| Potassium Chloride10MEQ · tablet, extended release;oral | Potassium Chloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
